Action 2372 I'ROM GROUP CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues I'rom Group Co., Ltd.

Actions

2372

JP3105170009

Marché Fermé - Japan Exchange
Autres places de cotation
 08:00:00 26/04/2024 		Varia. 5j. Varia. 1 janv.
1 800 JPY +0,28 % Graphique intraday de I'rom Group Co., Ltd. +1,98 % -10,40 %
2023 I'rom Group Co. annonce ses résultats pour l'exercice clos le 31 mars 2023 CI
2022 Lupin s'associe à I'rom Group pour commercialiser le denosumab au Japon MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
I'rom Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023
Lupin Ties Up with I'rom Group to Commercialize Denosumab in Japan
Lupin and I'rom Enter into an Exclusive Licensing Agreement for Denosumab Biosimilar for Japan
Cogsmart Co., Ltd. announced that it has received ¥350 million in funding from Omron Ventures Co., Ltd., I'rom Group Co., Ltd., DG Daiwa Ventures Inc., IT-Farm Corporation, Makoto Capital Co., Ltd. and other investors
I'rom Group Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2021, Payable June 29, 2021 and Provided Dividend Guidance for the Second Quarter and Fiscal Year 2022
I'rom Group Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 2019; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 2020; Provides Year End Dividend for the Year Ending March 31, 2020
Tranche Update on I'rom Group Co., Ltd.'s Equity Buyback Plan announced on February 26, 2019.
I'rom Group Co., Ltd.'s Equity Buyback announced on February 26, 2019 has expired with 124,300 shares for ¥199.89 million.
I'rom Group Co., Ltd. announces an Equity Buyback for 130,000 shares, representing 1.12% for ¥200 million.
I'rom Group Co., Ltd. authorizes a Buyback Plan.
Tranche Update on I'rom Group Co., Ltd.'s Equity Buyback Plan announced on November 8, 2018.
I'rom Group Co., Ltd.'s Equity Buyback announced on November 8, 2018 has expired with 89,800 shares for ¥199.86 million.
I'rom Group Co., Ltd. announces an Equity Buyback for 110,000 shares, representing 0.94% for ¥200 million.
I'rom Group Co., Ltd. authorizes a Buyback Plan.
I'rom Group Co., Ltd.(TSE:2372) added to S&P Global BMI Index
An undisclosed buyer cancelled the acquisition of I'rom OK Co., Ltd. from I'rom Group Co., Ltd..
I'rom Group Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 2017; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 2018
I'rom Group Co., Ltd. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2017; Provides Earnings Guidance for the Fiscal Year Ending March 2018; Declares Dividend for the Second Quarter of Fiscal 2018, Payable on December 15, 2017
OKEIOS Co., Ltd. announced that it has received funding from I'rom Group Co., Ltd.
I'rom Group Co., Ltd. completed the acquisition CMAX Clinical Research Pty Ltd from IDT Australia Limited for AUD 16.2 million.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 2372
  4. Actualités I'rom Group Co., Ltd.
  5. Autres langues